CoChat

Efficacy of self‐monitoring of blood glucose versus retrospective continuous glucose monitoring in improving glycaemic control in diabetic kidney disease patients

Yeoh, Ester, Lim, Boon Khim, Fun, Sharon, Tong, Julia, Yeoh, Lee Ying, Sum, Chee Fang, Subramaniam, Tavintharan, Lim, Su Chi · 2018 · Nephrology
Cited by 27

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Aims: Patients with diabetic kidney disease (DKD) on anti‐diabetic agents, are at greater risk of glycemic variations, both hypoglycemia and hyperglycemia. We aimed to compare glycemic control (using HbA1c) and hypoglycemia incidence in patients with Stage 3 DKD (eGFR 30–60 mL/min per 1.73 m 2), receiving retrospective CGM‐guided anti‐diabetic therapy versus self‐monitoring of blood glucose (SMBG) over 3 months. Methods: Thirty patients with HbA1c >8% were randomized to 6‐day retrospective CGM or SMBG. In the CGM group, CGM was worn at the beginning and 6 weeks. HbA1c, assessment of hypoglycaemia events (self‐reported and BG < 4 mmol/L from CGM/SMBG data) and medication adjustment were performed at baseline and 3 months. All patients received education on hypoglycaemia avoidance. Results: Fourteen patients were allocated to CGM and 16 to SMBG. Mean (±SD) eGFR was 42.9 ± 10.3 mL/min. Majority (86.7%) of patients had diabetes duration >10 years and on insulin therapy (90%). HbA1c improved significantly from baseline 9.9 ± 1.2 to 9.0 ± 1.5% (P < 0.001) at 3 months, with no difference between CGM (9.8 ± 1.2 to 8.8 ± 1.8%, P = 0.009) or SMBG (9.9 ± 1.3 to 9.1 ± 1.1%, P = 0.007) groups (P = 0.869 between groups). In the CGM group, percentage duration in hyperglycaemia (BG > 10 mmol/L) reduced from baseline 65.4 ± 22.4% to 54.6 ± 23.6% (P = 0.033) at 6 weeks, with a non‐significant rise in percentage duration in hypoglycaemia from 1.2 ± 2.2% to 4.0 ± 7.0% (P = 0.176). There was no difference in self‐reported and documented hypoglycaemia events. Conclusion: In a pilot study of DKD patients, short‐term episodic use of CGM reduced time spent in hyperglycaemia range without significantly increasing time‐exposure to hypoglycaemia. However, both CGM and SMBG were equally effective in improving glycaemic control.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/nep.12978

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 13

  1. 10.1038/kisup.2012.73 · DOI · Paper page
  2. 10.1053/j.ajkd.2007.08.012 · DOI
  3. 10.2337/diacare.24.5.909 · DOI · Paper page
  4. Low SK, 2015, Prevalence of Chronic Kidney Disease in Adults with Type 2 Diabetes Mellitus, Ann. Acad. Med. Singapore, 44, 164, 10.47102/annals-acadmedsg.V44N5p164 · DOI · Paper page
  5. 10.1053/j.ajkd.2008.04.011 · DOI
  6. 10.2337/dc15-0090 · DOI · Paper page
  7. 10.1185/03007990903094452 · DOI
  8. 10.1016/j.diabet.2015.07.001 · DOI
  9. 10.7326/0003-4819-150-9-200905050-00006 · DOI · Paper page
  10. 10.1177/0300060515600190 · DOI · Paper page
  11. Pepper GM, 2012, Effect of short‐term iPRO continuous glucose monitoring on hemoglobin A1c levels in clinical practice, Diabetes Technol. Ther., 14, 654, 10.1089/dia.2012.0030 · DOI
  12. 10.1177/1932296815581052 · DOI · Paper page
  13. Huntsman MA, Pain reduction and financial incentives to improve glucose monitoring adherence in a community health center, PLoS One, 9, e114875, 10.1371/journal.pone.0114875 · DOI

Cited by

Metadata

Authors
Yeoh, E., Lim, B. K., Fun, S., Tong, J., Yeoh, L. Y., Sum, C. F., Subramaniam, T., & Lim, S. C.
Venue
Nephrology
Publisher
Wiley
Published
2018-02-20
Volume
23
Issue
3
Pages
264-268
ISSN
  • 1320-5358 (ISSN-L)
  • 1440-1797
OpenAlex
W2560727373
Cited by
27
References
5
FWCI
1.73
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.